TC BioPharm (Holdings) PLC (TCBP)

0.6679 +0.01 (+1.35%) USD  |  NASDAQ  |  Dec 20, 16:00
0.66 -0.01 (-1.18%) After-Hours: 20:00
More

TC BioPharm Enterprise Value: 4.212M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for TCBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Adaptimmune Therapeutics PLC 18.53M
Biodexa Pharmaceuticals PLC -3.645M
Verona Pharma PLC 3.226B
NuCana PLC -10.48M
Autolus Therapeutics PLC -47.65M

Enterprise Value Related Metrics

Net Income (Quarterly) -2.506M
Total Expenses (Quarterly) 2.592M
EPS Diluted (Quarterly) -5.068
Earnings Yield -10.58K%